Today we are proud to mark World Evidence-Based Healthcare (EBHC) Day, a global initiative to highlight the critical role of evidence in improving health outcomes, enhancing clinical care, and informing policy .

The 2022 World EBHC Day campaign focuses on partnerships within the global evidence ecosystem that are working to bridge research, policy, and practice, and realize the potential of evidence-based health care.

CADTH is pleased to announce the launch of its new Post-Market Drug Evaluation Program.

This important initiative fills a key gap in Canada’s drug safety and effectiveness landscape and is an exciting example of how CADTH is delivering on the “Innovate” pillar from its 2022-2025 Strategic Plan.

We recently experienced problems with its website hosting platform that prevented users from downloading documents from cda-amc.ca – including draft reimbursement recommendations and stakeholder feedback forms.

The issue has been resolved and all documents on our website are now accessible to everyone.

When the problem was identified, we contacted sponsors and patient groups and provided them with copies of the draft recommendations and feedback forms for the reimbursement reviews currently open for feedback. Sponsors also received the reconsideration forms.